Promising Results In Early Trial of Novel MS Treatment



Embed Code

Copy/paste the following code


Reporting in the journal Science Translational Medicine researchers say a new method for essentially resetting the immune systems of patients with multiple sclerosis appears to be safe. Study co-author Stephen D. Miller of Northwestern University, describes the novel approach tested in this small, phase 1 clinical trial and explains how it might one day also be used to treat other autoimmune diseases such as type 1 diabetes.

Copyright 2016 NPR. To see more, visit

Copyright NPR. View this article on